{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:14:11Z","timestamp":1791000851538,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:00:00Z","timestamp":1469145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:00:00Z","timestamp":1469145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maternal inflammation contributes to the increased incidence of adult cardiovascular disease. The current study investigated the susceptibility of cardiac damage responding to isoproterenol (ISO) in adult offspring that underwent maternal inflammation (modeled by pregnant Sprague-Dawley rats with lipopolysaccharides (LPS) challenge). We found that 2 weeks of ISO treatment in adult offspring of LPS-treated mothers led to augmented heart damage, characterized by left-ventricular systolic dysfunction, cardiac hypertrophy and myocardial fibrosis. Mechanistically, prenatal exposure to LPS led to up-regulated expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, antioxidant enzymes, and p38 MAPK activity in left ventricular of adult offspring at resting state. ISO treatment exaggerated ROS generation, p38 MAPK activation but down-regulated reactive oxygen species (ROS) elimination capacity in the left ventricular of offspring from LPS-treated mothers, while antioxidant N-acetyl-L-cysteine (NAC) reversed these changes together with improved cardiac functions. The p38 inhibitor SB202190 alleviated the heart damage only via inhibiting the expression of NADPH oxidases. Collectively, our data demonstrated that prenatal inflammation programs pre-existed ROS activation in the heart tissue, which switches on the early process of oxidative damages on heart rapidly through a ROS-p38 MAPK-NADPH oxidase-ROS positive feedback loop in response to a myocardial hypertrophic challenge in adulthood.<\/jats:p>","DOI":"10.1038\/srep30146","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T09:14:26Z","timestamp":1469178866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation"],"prefix":"10.1038","volume":"6","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongshan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Namaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,22]]},"reference":[{"key":"BFsrep30146_CR1","unstructured":"World Health Organization. Global Atlas on cardiovascular disease prevention and control. WHO Publications: Geneva (2011)."},{"key":"BFsrep30146_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","volume":"60","author":"LJ Laslett","year":"2012","unstructured":"Laslett, L. J. et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol 60, S1\u201349 (2012).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep30146_CR3","first-page":"9","volume":"8","author":"GBS Tobias Esch","year":"2002","unstructured":"Tobias Esch, G. B. S., Gregory, L., Fricchione & Herbert Benson. Stress in cardiovascular diseases. Med Sci Monit 8, 9 (2002).","journal-title":"Med Sci Monit"},{"key":"BFsrep30146_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1152\/physrev.00007.2009","volume":"90","author":"SC MALPAS","year":"2010","unstructured":"MALPAS, S. C. Sympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular Disease. Physiol Rev 90, 45 (2010).","journal-title":"Physiol Rev"},{"key":"BFsrep30146_CR5","first-page":"594","volume":"17","author":"D Hering","year":"2015","unstructured":"Hering, D., Lachowska, K. & Schlaich, M. Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease. Curr Hypertens Rep 17, 594 (2015).","journal-title":"Curr Hypertens Rep"},{"key":"BFsrep30146_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10286-012-0162-x","volume":"22","author":"YB Sverrisdottir","year":"2012","unstructured":"Sverrisdottir, Y. B., Schultz, T., Omerovic, E. & Elam, M. Sympathetic nerve activity in stress-induced cardiomyopathy. Clin Auton Res 22, 259\u201364 (2012).","journal-title":"Clin Auton Res"},{"key":"BFsrep30146_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos, A., Rengo, G. & Koch, W. J. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 113, 739\u201353 (2013).","journal-title":"Circ Res"},{"key":"BFsrep30146_CR8","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/CIRCULATIONAHA.113.001805","volume":"129","author":"W Palinski","year":"2014","unstructured":"Palinski, W. Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease. Circulation 129, 2066\u201377 (2014).","journal-title":"Circulation"},{"key":"BFsrep30146_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1549-8719.2011.00097.x","volume":"18","author":"L Leach","year":"2011","unstructured":"Leach, L. & Mann, G. E. Consequences of fetal programming for cardiovascular disease in adulthood. Microcirculation 18, 253\u20135 (2011).","journal-title":"Microcirculation"},{"key":"BFsrep30146_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1161\/CIRCULATIONAHA.107.750133","volume":"117","author":"W Palinski","year":"2008","unstructured":"Palinski, W. & Napoli, C. Impaired fetal growth, cardiovascular disease, and the need to move on. Circulation 117, 341\u20133 (2008).","journal-title":"Circulation"},{"key":"BFsrep30146_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/bmj.308.6924.295","volume":"308","author":"PE Hay","year":"1994","unstructured":"Hay, P. E., R. F., Lamont, Taylor-Robinson, D. J., Morgan, C. Ison & J., Pearson Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 308, 5 (1994).","journal-title":"BMJ"},{"key":"BFsrep30146_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/S2040174409990031","volume":"1","author":"B Mazumder","year":"2010","unstructured":"Mazumder, B., Almond, D., Park, K., Crimmins, E. M. & Finch, C. E. Lingering prenatal effects of the 1918 influenza pandemic on cardiovascular disease. J Dev Orig Health Dis 1, 26\u201334 (2010).","journal-title":"J Dev Orig Health Dis"},{"key":"BFsrep30146_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1745-7254.2007.00593.x","volume":"28","author":"YL Wei","year":"2007","unstructured":"Wei, Y. L., Li, X. H. & Zhou, J. Z. Prenatal exposure to lipopolysaccharide results in increases in blood pressure and body weight in rats. Acta Pharmacologica Sinica 28, 651\u20136 (2007).","journal-title":"Acta Pharmacologica Sinica"},{"key":"BFsrep30146_CR14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1440-1681.2008.05062.x","volume":"35","author":"W Liao","year":"2008","unstructured":"Liao, W. et al. Prenatal exposure to zymosan results in hypertension in adult offspring rats. Clin Exp Pharmacol Physiol 35, 1413\u20138 (2008).","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFsrep30146_CR15","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.3390\/ijms160510986","volume":"16","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Prenatal exposure to lipopolysaccharide results in myocardial fibrosis in rat offspring. Int J Mol Sci 16, 10986\u201396 (2015).","journal-title":"Int J Mol Sci"},{"key":"BFsrep30146_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1476-9255-10-35","volume":"10","author":"Y Wei","year":"2013","unstructured":"Wei, Y. et al. Prenatal exposure to lipopolysaccharide results in myocardial remodelling in adult murine offspring. J Inflamm (Lond) 10, 35 (2013).","journal-title":"J Inflamm (Lond)"},{"key":"BFsrep30146_CR17","first-page":"6","volume":"57","author":"KR\u00c1\u013dOV\u00c1 E.","year":"2008","unstructured":"E., KR\u00c1\u013dOV\u00c1, T.M., J. MUR\u00cdN, T. STANKOVI\u010cOV\u00c1. Electrocardiography in two models of isoproterenol-induced left ventricular remodeling. Physiol. Res. 57, 6 (2008).","journal-title":"Physiol. Res."},{"key":"BFsrep30146_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pathophys.2012.04.004","volume":"19","author":"M Takaki","year":"2012","unstructured":"Takaki, M. Cardiac mechanoenergetics for understanding isoproterenol-induced rat heart failure. Pathophysiology 19, 163\u201370 (2012).","journal-title":"Pathophysiology"},{"key":"BFsrep30146_CR19","doi-asserted-by":"publisher","first-page":"B401","DOI":"10.1093\/gerona\/54.9.B401","volume":"54","author":"JR Stratton","year":"1999","unstructured":"Stratton, J. R. Effects of age and gender on the cardiovascular responses to isoproterenol. J Gerontol A Biol Sci Med Sci 54, B401\u20133 (1999).","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"BFsrep30146_CR20","doi-asserted-by":"publisher","first-page":"H256","DOI":"10.1152\/ajpheart.2002.282.1.H256","volume":"282","author":"VM Vizgirda","year":"2002","unstructured":"Vizgirda, V. M., Wahler, G. M., Sondgeroth, K. L., Ziolo, M. T. & Schwertz, D. W. Mechanisms of sex differences in rat cardiac myocyte response to beta-adrenergic stimulation. Am J Physiol Heart Circ Physiol 282, H256\u201363 (2002).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep30146_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4149\/gpb_2012_015","volume":"31","author":"Z Nichtova","year":"2012","unstructured":"Nichtova, Z., Novotova, M., Kralova, E. & Stankovicova, T. Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol. Gen Physiol Biophys 31, 141\u201351 (2012).","journal-title":"Gen Physiol Biophys"},{"key":"BFsrep30146_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.CIR.101.1.8","volume":"101","author":"G Martin St.","year":"2000","unstructured":"Martin, G. St., John Sutton, M. & FRCP, Norman Sharpe, MD FRACP. left ventricular remodeling after myocardial infarction pathophysiology and therapy. Circulation 101, 8 (2000).","journal-title":"Circulation"},{"key":"BFsrep30146_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/01.RES.86.1.6","volume":"86","author":"WM Setsuya Miyata","year":"2000","unstructured":"Setsuya Miyata, W. M., Michael R, Bristow & Leslie A, Leinwand. Myosin Heavy Chain Isoform Expression in the Failing and Nonfailing Human Heart. Circ Res 86, 6 (2000).","journal-title":"Circ Res"},{"key":"BFsrep30146_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","volume":"51","author":"K Sugamura","year":"2011","unstructured":"Sugamura, K. & Keaney, J. F. Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51, 978\u201392 (2011).","journal-title":"Free Radic Biol Med"},{"key":"BFsrep30146_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0027-5107(99)00010-X","volume":"424","author":"LJ Marnett","year":"1999","unstructured":"Marnett, L. J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 424, 83\u201395 (1999).","journal-title":"Mutat Res"},{"key":"BFsrep30146_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0009-8981(03)00200-6","volume":"333","author":"A Pastore","year":"2003","unstructured":"Pastore, A., Federici, G., Bertini, E. & Piemonte, F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 333, 19\u201339 (2003).","journal-title":"Clin Chim Acta"},{"key":"BFsrep30146_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"FJ Giordano","year":"2005","unstructured":"Giordano, F. J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115, 500\u20138 (2005).","journal-title":"J Clin Invest"},{"key":"BFsrep30146_CR28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bcpt.12405","volume":"117","author":"E Kralova","year":"2015","unstructured":"Kralova, E. et al. l-Arginine Attenuates Cardiac Dysfunction, But Further Down-Regulates alpha-Myosin Heavy Chain Expression in Isoproterenol-Induced Cardiomyopathy. Basic Clin Pharmacol Toxicol 117, 251\u201360 (2015).","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"BFsrep30146_CR29","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCRESAHA.111.300299","volume":"112","author":"VB Patel","year":"2013","unstructured":"Patel, V. B. et al. Loss of p47phox subunit enhances susceptibility to biomechanical stress and heart failure because of dysregulation of cortactin and actin filaments. Circ Res 112, 1542\u201356 (2013).","journal-title":"Circ Res"},{"key":"BFsrep30146_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/35040740","volume":"408","author":"NJH Toren Finkel","year":"2000","unstructured":"Toren Finkel, N. J. H. Oxidants, oxidative stress and the biology of ageing. nature 408, 10 (2000).","journal-title":"nature"},{"key":"BFsrep30146_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5493\/wjem.v5.i4.218","volume":"5","author":"V Lubrano","year":"2015","unstructured":"Lubrano, V. & Balzan, S. Enzymatic antioxidant system in vascular inflammation and coronary artery disease. World J Exp Med 5, 218\u201324 (2015).","journal-title":"World J Exp Med"},{"key":"BFsrep30146_CR32","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","volume":"1830","author":"Y Samuni","year":"2013","unstructured":"Samuni, Y., Goldstein, S., Dean, O. M. & Berk, M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 1830, 4117\u201329 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep30146_CR33","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose, B. A., Force, T. & Wang, Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90, 1507\u201346 (2010).","journal-title":"Physiol Rev"},{"key":"BFsrep30146_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.cardiores.2004.08.013","volume":"65","author":"GX Zhang","year":"2005","unstructured":"Zhang, G. X. et al. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 65, 230\u20138 (2005).","journal-title":"Cardiovasc Res"},{"key":"BFsrep30146_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jlb.64.3.409","volume":"64","author":"CL Manthey","year":"1998","unstructured":"Manthey, C. L., Wang, S. W., Kinney, S. D. & Yao, Z. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64, 409\u201317 (1998).","journal-title":"J Leukoc Biol"},{"key":"BFsrep30146_CR36","first-page":"14","volume":"115","author":"Bakin Andrei V","year":"2002","unstructured":"Andrei V, Bakin & Anne K, C. R. Tomlinson and Carlos L. Arteaga. p38 mitogen-activated protein kinase is required for TGF\u03b2-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115, 14 (2002).","journal-title":"J Cell Sci"},{"key":"BFsrep30146_CR37","first-page":"7","volume":"49","author":"M Weike Bao","year":"2007","unstructured":"Weike Bao, M., David J, Behm, MS, Sandhya S, Nerurkar, MS, Zhaohui, Ao, MD, Ross Bentley, B., Rosanna C, Mirabile, MS, Douglas G, Johns, PhD, Tina N, Woods, MS, Christopher, P. A., Doe, P., Robert W, Coatney, PhD, Jason F, Ohlstein, BS, Stephen, A., Douglas, P., Robert N, Willette, PhD & Tian-Li, Yue, PhD . Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. J Cardiovasc Pharmacol TM 49, 7 (2007).","journal-title":"J Cardiovasc Pharmacol TM"},{"key":"BFsrep30146_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cardiores.2004.03.008","volume":"63","author":"J Widder","year":"2004","unstructured":"Widder, J. et al. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent. Cardiovasc Res 63, 161\u20137 (2004).","journal-title":"Cardiovasc Res"},{"key":"BFsrep30146_CR39","unstructured":"World Health Organization. Global status report on communicable diseases. WHO Publications: Geneva (2014)."},{"key":"BFsrep30146_CR40","first-page":"6","volume":"84","author":"C Rebecca","year":"2006","unstructured":"Rebecca, C., Painter, S.R.d.R., Patrick M, Bossuyt, Timothy A, Simmers, Clive, Osmond, David J, Barker, Otto P, Bleker & Tessa J, Roseboom . Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am J Clin Nutr 84, 6 (2006).","journal-title":"Am J Clin Nutr"},{"key":"BFsrep30146_CR41","first-page":"11","volume":"6","author":"KRH Markus Velten","year":"2011","unstructured":"Markus Velten, K. R. H., Matthew W, Gorr, Loren E, Wold, Pamela A, Lucchesi & Lynette K, Rogers. Systemic maternal inflammation and neonatal hyperoxia induces remodeling and left ventricular dysfunction in mice. PLoS One 6, 11 (2011).","journal-title":"PLoS One"},{"key":"BFsrep30146_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yjmcc.2012.12.007","volume":"55","author":"S Turdi","year":"2013","unstructured":"Turdi, S. et al. Interaction between maternal and postnatal high fat diet leads to a greater risk of myocardial dysfunction in offspring via enhanced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects. J Mol Cell Cardiol 55, 117\u201329 (2013).","journal-title":"J Mol Cell Cardiol"},{"key":"BFsrep30146_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S000711450769182X","volume":"98","author":"MJ Elmes","year":"2007","unstructured":"Elmes, M. J., Gardner, D. S. & Langley-Evans, S. C. Fetal exposure to a maternal low-protein diet is associated with altered left ventricular pressure response to ischaemia-reperfusion injury. Br J Nutr 98, 93\u2013100 (2007).","journal-title":"Br J Nutr"},{"key":"BFsrep30146_CR44","doi-asserted-by":"publisher","first-page":"21692","DOI":"10.1038\/srep21692","volume":"6","author":"Y Deng","year":"2016","unstructured":"Deng, Y. et al. Prenatal inflammation-induced NF-kappaB dyshomeostasis contributes to renin-angiotensin system over-activity resulting in prenatally programmed hypertension in offspring. Sci Rep 6, 21692 (2016).","journal-title":"Sci Rep"},{"key":"BFsrep30146_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1469-8986.1986.tb00602.x","volume":"23","author":"A Sherwood","year":"1986","unstructured":"Sherwood, A., Allen, M. T., Obrist, P. A. & Langer, A. W. Evaluation of beta-adrenergic influences on cardiovascular and metabolic adjustments to physical and psychological stress. Psychophysiology 23, 89\u2013104 (1986).","journal-title":"Psychophysiology"},{"key":"BFsrep30146_CR46","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.ijcard.2012.12.092","volume":"168","author":"Y Shao","year":"2013","unstructured":"Shao, Y. et al. Novel rat model reveals important roles of beta-adrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol 168, 1943\u201350 (2013).","journal-title":"Int J Cardiol"},{"key":"BFsrep30146_CR47","first-page":"10","volume":"301","author":"SK Hiroyuki Tsutsui","year":"2011","unstructured":"Hiroyuki Tsutsui, S. K. & Shouji, Matsushima. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301, 10 (2011).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep30146_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.scr.2013.09.012","volume":"12","author":"A Sato","year":"2014","unstructured":"Sato, A. et al. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Res 12, 119\u201331 (2014).","journal-title":"Stem Cell Res"},{"key":"BFsrep30146_CR49","first-page":"6","volume":"8","author":"SS Shailja Gupta","year":"2009","unstructured":"Shailja Gupta, S. S. & Vivek, Mahajan. Correlation of antioxidants with lipid peroxidation and lipid profile in patients suffering from coronary artery disease. Expert Opin. Ther. Targets 8, 6 (2009).","journal-title":"Expert Opin. Ther. Targets"},{"key":"BFsrep30146_CR50","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","volume":"116","author":"Y Wang","year":"2007","unstructured":"Wang, Y. Mitogen-activated protein kinases in heart development and diseases. Circulation 116, 1413\u201323 (2007).","journal-title":"Circulation"},{"key":"BFsrep30146_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","volume":"44","author":"RM Touyz","year":"2004","unstructured":"Touyz, R. M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248\u201352 (2004).","journal-title":"Hypertension"},{"key":"BFsrep30146_CR52","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2015.02.012","volume":"169","author":"ML O'Donoghue","year":"2015","unstructured":"O'Donoghue, M. L. et al. Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. Am Heart J 169, 622\u2013630 e6 (2015).","journal-title":"Am Heart J"},{"key":"BFsrep30146_CR53","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0140-6736(14)60417-7","volume":"384","author":"LK Newby","year":"2014","unstructured":"Newby, L. K. et al. Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial. Lancet 384, 1187\u201395 (2014).","journal-title":"Lancet"},{"key":"BFsrep30146_CR54","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/pr.2013.40","volume":"73","author":"A Rideau Batista Novais","year":"2013","unstructured":"Rideau Batista Novais, A. et al. N-acetyl-cysteine prevents pyramidal cell disarray and reelin-immunoreactive neuron deficiency in CA3 after prenatal immune challenge in rats. Pediatr Res 73, 750\u20135 (2013).","journal-title":"Pediatr Res"},{"key":"BFsrep30146_CR55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jss.2008.04.030","volume":"152","author":"AW O'Sullivan","year":"2009","unstructured":"O'Sullivan, A. W., Wang, J. H. & Redmond, H. P. NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. J Surg Res 152, 46\u201353 (2009).","journal-title":"J Surg Res"},{"key":"BFsrep30146_CR56","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.4049\/jimmunol.1302600","volume":"193","author":"Y Deng","year":"2014","unstructured":"Deng, Y. et al. The natural product phyllanthusmin C enhances IFN-gamma production by human NK cells through upregulation of TLR-mediated NF-kappaB signaling. J Immunol 193, 2994\u20133002 (2014).","journal-title":"J Immunol"},{"key":"BFsrep30146_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.immuni.2015.02.006","volume":"42","author":"Y Deng","year":"2015","unstructured":"Deng, Y. et al. Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function. Immunity 42, 457\u2013470 (2015).","journal-title":"Immunity"},{"key":"BFsrep30146_CR58","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.1073\/pnas.0510444103","volume":"103","author":"M Satoh","year":"2006","unstructured":"Satoh, M. et al. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 103, 7432\u20137 (2006).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep30146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30146","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T11:21:18Z","timestamp":1718709678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep30146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,22]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,28]]}},"alternative-id":["BFsrep30146"],"URL":"https:\/\/doi.org\/10.1038\/srep30146","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,22]]},"assertion":[{"value":"22 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30146"}}